We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BARR ACQUIRES GALEN'S LOESTRIN UNDER FINAL AGREEMENT
BARR ACQUIRES GALEN'S LOESTRIN UNDER FINAL AGREEMENT
March 25, 2004
Barr Pharmaceuticals and Galen Holdings have finalized agreements that give Barr exclusive rights to Galen’s Loestrin oral contraceptive products and Galen the option to market Barr’s generic version of its own oral contraceptive Ovcon 35.